{"url_path":"/sec/engn/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1980845/0001193125-26-344559-index.html","accession_number":"0001193125-26-344559","cik":"0001980845","ticker":"ENGN","issuer_name":"enGene Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1980845/0001193125-26-344559-index.html","primary_entity_key":"0001980845","primary_entity_name":"enGene Therapeutics Inc."},"word_count":88,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n## (d) Exhibits\n\nExhibit No.\n\n \n\nDescription of Exhibits\n\n[99.1](engn-ex99_1.htm)\n\n \n\n[Virtual KOL Event Slide Presentation, dated August 11, 2026](engn-ex99_1.htm)\n\n104\n\n \n\nCover Page Interactive Data File (Formatted as Inline XBRL)\n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nENGENE THERAPEUTICS INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nAugust 11, 2026\n\nBy:\n\n/s/ Ronald H. W. Cooper\n\n \n\n \n\n \n\nName: Ronald H. W. Cooper\nTitle: Chief Executive Officer and President"}